Skip to content
Study details
Enrolling now

Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty

Hospital for Special Surgery, New York
NCT IDNCT05981105ClinicalTrials.gov data as of Apr 2026
Target enrollment

64

Study length

about 1.6 years

Ages

18–75

Locations

1 site in NY

About this study

Researchers are testing whether using an adductor canal catheter (ACC) reduces opioid use 24-48 hours after surgery compared to a sham catheter in patients undergoing total knee arthroplasty. Participants will be randomized to receive either the ACC or a sham catheter and asked to communicate with their pain doctor through a mobile app while the catheter is in place. The trial will last up to 6 months post-operation, and researchers will compare opioid use and chronic pain between the two groups at that time.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Use ambIT pump with catheter
  • 2.Use ambIT pump with sham catheter

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low7%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Secondary: Hospital Length of Stay, Incidences of participants readmitted for pain control, Knee injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR.), Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), Non Opioid Pain medications consumption, Numerical Pain Rating Score, Opioid Related Symptom Distress Scale (ORSDS), Pain Disability Index (PDI)

Devices

therapeutic

Body systems

Psychiatry / Mental Health